Their reply is not vague at all. It couldn't be more straight forward. Some very bold assumptions coming from you. Sounds like you have made up a story to suit your own needs.
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025